RoX Health’s Post

What sets a truly disruptive startup apart? 💡 Its ability to be recognized as one of the most promising in Europe during its early stages is definitely a strong indicator of success!! 🚀 🏆 At S2 Xpeed, we are thrilled to share that Time is Brain has been featured by Sifted in their latest Medtech Briefing as one of the early-stage startups to watch in Europe. This recognition, awarded by one of the most influential media brands in the European startup community and backed by the Financial Times, not only acknowledges the incredible work Time is Brain is doing in the field of medical technology, but also underscores the impact we aim to drive through our acceleration programs. Time is Brain’s advancements in stroke diagnosis and improved patient care are a clear example of how innovation can transform key sectors like healthcare. 💡 And this is just one example of the immense potential of the startups participating in our programs. We are proud to see how, step by step, the companies we accelerate are making a real difference in their respective fields. Thank you to Sifted for recognizing this mission, and to Time is Brain for being a shining example of what it means to accelerate innovation🚀 Alicia Martínez Piñeiro, Blas Diaz, Gisela Ruiz Vega #StartupsToWatch #medtech #innovation #corporateventuring #S2Xpeed

Do you have any plans for next week? We have, we will be at the 4YFN! On the days 26th and 27th, we will have all hands on deck at our booth in the Catalonia Health Innovation Ecosystem Pavilion Hall 8.1 - Stand 8.1A40 and on the 27th we will join Banco Sabadell at his pavilion. If you didn't have plans, now you might have. Do you feel like joining the 4YFN and visiting us? #MWC24, #4YFN24, #startups, #spinoff, #medtech, #innovation, #neurosciences, #medicaldevices, #interventionalradiology, #neuroradiology, #ai, #timeisbrain, #brain20, #strokeismypriority, #greaterthanstroke

“The key, for entrepreneurs, is to think about what is the highest impact thing that I can do, what is the critical milestone that I can achieve to get to the next point where I can raise some additional capital.” Meet Timothy Boire and Geoffrey Lucks, co-founders of VenoStent, Inc., who are tackling a major challenge in dialysis access. Tim is a biomedical engineer who discovered the Achilles heel of vascular surgery during his time as an entrepreneurial lead at National Science Foundation (NSF) I-Corps. Geoffrey, on the other hand, has a Master's in Bioethics from the University of Pennsylvania and an MBA in Finance from Vanderbilt University, where the two met. Their product, SelfWrap, is a bioabsorbable wrap to improve the success rate of vascular surgeries. It could mean fewer complications, better outcomes, and longer-lasting access points. Here’s an inside peak at their conversation with Scott Nelson: 👍🏽 In medtech, the first task is to prove your concept. Thoroughly research your space, seek feedback from clinical experts throughout the entire process, and engage with partners who can offer the expertise that you need in your product development. 📐 Showcase your market savvy by demonstrating a real problem, a working solution, and a sizable market. Then build early prototypes, learn from them, and continuously improve. Get your device into the hands of potential users as soon as possible and seek early feedback. 👨🏻🤝👨🏽Forging a collaborative relationship is the golden rule for navigating regulatory interactions. Understand FDA’s perspective, follow their guidance, and foster transparency. At the same time, make sure you capitalize on the advantages of your chosen regulatory pathway and position your device accordingly. Check out the full interview in the comments below. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We just launched Medsider Mentors Volume VI, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.

Explore in Berlin the latest update about longevity innovation

The call is open for two innovation challenges with Roche Farma España! More information and applications here: https://lnkd.in/g2qb-zBa Deadline April 19. This Innovation Program aims to foster innovation in Hepatocellular Carcinoma and Ophthalmology. It offers a privileged environment for startups and hospital projects that offer disruptive solutions to improve patients' lives with these pathologies. This is an open call for startups and disruptive hospital projects with a product developed and ready to be tested. The selected participants will work with Roche Pharma Spain with the support of Plug and Play and the program expert committee, receiving mentoring and training sessions on key topics for the growth and scaling of their solution. STARTUP CREASPHERE powered by Plug and Play #PNPTC #DigitalHealth #CorporateInnovation #HospitalProjects

On April 25th, 20 startups will have just 90 seconds to convince you that their technology can change the world. Click here to register ➡ https://lnkd.in/e_28WFzq Discover the second group that will pitch on stage! 🔘 Magnetfab: Magnetfab innovates by producing thousands of integrated micromagnets on wafers, each tiny yet powerful. Their ambition is to build the world's first micromagnet foundry, becoming a key player in the MEMS industry’s supply chain. Represented by Milan Calic, founder. 💆♀️ PhenomX Health: The startup aims to enhance the wellbeing, vitality and longevity of 1B menopausal women. They are offering a personalized digital platform empowering peri to post menopausal women to optimize their health and businesses. Represented by Dr. Colleen Fogarty Draper PhD, RD, Co-founder & CEO. 📋 HepaVue : Over 2 billion people suffer from chronic liver disease, yet needle biopsy remains the only diagnostic option. HepaVue introduces the world’s first virtual liver biopsy, making liver disease diagnosis affordable, painless, safe and more accessible. Represented by Maxime Nachit, Co-founder & CEO. 🚼 NEOSENS: NEOSENS offers a platform AI-based Diagnostic Assistant for rapid health assessment in newborns, initially focusing on early sepsis detection. Represented by Mateo Hamel, Co-founder. 👨💼 PitchMe: Vertical-axis wind turbines are quiet, fauna-friendly and require less space than traditional windmills. Despite challenges in efficiency and lifespan, PitchMe’s data-driven blade pitch control software maximizes their potential. Represented by Sébastien Le Fouest, Co-founder. Many thanks to our sponsors: Swisscom, EY, Kellerhals Carrard, Alpian, Innovaud and Superlab Suisse. #SUChamps #Innovation #Startup EPFL Startup Venturelab

Celebrating Innovation: b-rayZ Earns Prestigious Innosuisse Certificate for Startup Excellence! 🤩 The award of the certificate underscores our commitment to sustainable growth and innovation. It is granted to startups that demonstrate remarkable progress and readiness for scaling, following a rigorous Core Coaching programme. The Innosuisse Certificate is not just an award; it's a testament to a startup's solid foundation, capability for handling future growth, and readiness to engage in a broad market. It reflects a startup’s proficiency in accessing and establishing a significant presence within the industry. Achieving this certificate involved a meticulous evaluation process, including a formal review and a presentation to a committee of experts, showcasing our progress and potential. We are set to leverage these opportunities to the fullest, driving forward our mission to revolutionize healthcare through innovative technology. We owe a huge part of this success to our long-term mentor and lead coach, Dr. Heiko Visarius, whose guidance has been invaluable. Dr. Visarius, thank you for your unwavering support and for pushing us to achieve our best. #innosuise #startup #ai #breastimaging #breastcancer #artificialintelligence #radiology

Program and full speaker list of the #RejuvenationStartupSummit 2024 (May 10-11) released today! Join the largest gathering of longevity CEOs in person and get your ticket as long as it is Early Bird (Early Bird pricing ends March 1)! Starting midday on Friday and finishing off on Saturday night with a big party, it offers ample opportunity to get in touch, learn, and network with some of the most promising companies in the rejuvenation/longevity field like: * Mehmood Khan, CEO of the Hevolution Foundation * Nina Ruge, science journalist and best-selling author  * Dobri Kiprov, CSO of Lyfspn  * Greg Fahy, CSO, and Robert T. (Bobby) Brooke, CEO and CTO of Intervene Immune * Aaron Friedman, CEO, and Vlad Senatorov, CSO of Reservoir Neuroscience * Marco Quarta, CEO Rubedo Life Sciences * Robin Mansukhani, CEO of Deciduous Therapeutics * Matthias Breugelmans, CEO, and Naren Vyavahare, CSO of Elastrin Therapeutics * Alex Blyth, CEO of LIfT BioSciences  * Ann Belien, PhD Belien, CEO of Rejuvenate Biomed  * Michael Kope, and Matthew "Oki" O'Connor, Co-CEOs of Cyclarity * Lukas Langenegger, CEO of Hemotune * Aaron Cravens, CEO of REVEL  * Christopher Bradley, CEO of MatterBio * Nikolina Lauc, CEO of Glycan Age  * Janine Sengstack, Co-founder and CEO, and Rob Carhill, Co-Founder and President of Junevity * Reason, CEO and Mourad Topors, CSO of Repair Biotechnologies * Alexander Leutner, Managing Director of cellbricks * Dr. Alexander Schueller, CEO, and Stephen Helliwell, CSO of cellvie * Louis Hawthorne, CEO of NaNotics  * Celine Halioua, CEO of Loyal * Phil Newman, CEO of Longevity.Technology * Stephanie Lauren Dainow , Executive Director of Lifespan.io  * Francois Casanova, CEO of AYUN Health & Longevity Center * Joanna Bensz, CEO of Longevity Center Europe * Sophie Chabloz, CPO of Avea  * Lorna Harries, CSO of Senisca * Alejandro Ocampo, Co-founder and CEO of Epiterna * Juergen Reess, CEO of Mogling Bio * Petr Sramek, Co-founder of the Healthy Longevity Clinic and Managing Partner of LongevityTech.fund * Brian Kennedy, Prof. at National University of Singapore * Eric Verdin, CEO and President of the Buck Institute for Research on Aging Investors on stage: * Jens Eckstein, Investment Partner at Hevolution * Alex Colville, Co-founder and General Partner at Age1 * Jan Adams, Partner at Apollo Health Ventures * Sergey Jakimov, Managing Partner at LongeVC * Marc P. Bernegger, Founding Partner at maximon * Patrick Burgermeister, Partner at Kizoo Technology Capital Please find the full conference program featuring over 40 speakers leading the industry here: https://lnkd.in/e6Fv8bVG Early bird pricing for the Rejuvenation Startup Summit 2024 ends March 1! Get your tickets here: https://lnkd.in/emmPysKd #RejuvenationStartupSummit #longevity #aging #ageing #rejuvenation 

Announcing the Open Call for two innovation challenges with Roche Farma España This Innovation Program aims to foster innovation in Hepatocellular Carcinoma and Ophthalmology. It offers a privileged environment for startups and hospital projects that offer disruptive solutions to improve patients' lives with these pathologies. This is an open call for startups and disruptive hospital projects with a product developed and ready to be tested. The selected startups and hospital projects will work with Roche Pharma Spain with the support of Plug and Play and the program expert committee, receiving mentoring and training sessions on key topics for the growth and scaling of their solution. More information and applications here: https://lnkd.in/g2qb-zBa Deadline April 19. STARTUP CREASPHERE powered by Plug and Play #PNPTC #DigitalHealth #CorporateInnovation #HospitalProjects

Announcing the Open Call for two innovation challenges with Roche Farma España This Innovation Program aims to foster innovation in Hepatocellular Carcinoma and Ophthalmology. It offers a privileged environment for startups and hospital projects that offer disruptive solutions to improve patients' lives with these pathologies. This is an open call for startups and disruptive hospital projects with a product developed and ready to be tested. The selected startups and hospital projects will work with Roche Pharma Spain with the support of Plug and Play and the program expert committee, receiving mentoring and training sessions on key topics for the growth and scaling of their solution. More information and applications here: https://lnkd.in/g2qb-zBa Deadline April 19. STARTUP CREASPHERE powered by Plug and Play #PNPTC #DigitalHealth #CorporateInnovation #HospitalProjects